首页> 外文期刊>Case Reports in Surgery >Surgical Management of Encapsulating Peritoneal Sclerosis: A Case Report in Kidney Transplant Patient
【24h】

Surgical Management of Encapsulating Peritoneal Sclerosis: A Case Report in Kidney Transplant Patient

机译:封装性腹膜硬化的外科治疗:肾移植患者的一例报告。

获取原文
       

摘要

Introduction. Encapsulating peritoneal sclerosis (EPS) is a clinical syndrome of progressive fibrotic change in response to prolonged, repetitive, and typically severe insult to the peritoneal mesothelium, often occurring in the setting of peritoneal dialysis (PD). Clear guidelines for successful management remain elusive. We describe the successful surgical management of EPS in a 28-year-old male s/p deceased donor kidney transplant for end-stage renal disease (ESRD) secondary to focal segmental glomerulosclerosis (FSGS). This patient received PD for 7 years but changed to hemodialysis (HD) in the year of transplant due to consistent signs and symptoms of underdialysis. EPS was visualized at the time of transplant. Despite successful renal transplantation, EPS progressed to cause small bowel obstruction (SBO) requiring PEG-J placement for enteral nutrition and gastric decompression. The patient subsequently developed a chronic gastrocutaneous fistula necessitating chronic TPN and multiple admissions for pain crises and bowel obstruction. He was elected to undergo surgical intervention due to deteriorating quality of life and failure to thrive. Surgical management included an exploratory laparotomy with extensive lysis of adhesions (LOA), repair of gastrocutaneous fistula, and end ileostomy with Hartmann’s pouch. Postoperative imaging confirmed resolution of the SBO, and the patient was transitioned to NGT feeds and eventually only PO intake. He is continuing with PO nutrition, gaining weight, and free from dialysis. Conclusion. Surgical intervention with LOA and release of small intestine can be successful for definitive management of EPS in the proper setting. In cases such as this, where management with enteral nutrition fails secondary to ongoing obstructive episodes, surgical intervention can be pursued in the interest of preserving quality of life.
机译:介绍。包膜性腹膜硬化症(EPS)是一种临床症状,是对腹膜间质的长期,重复性且通常是严重的侮辱所引起的进行性纤维化改变,通常在腹膜透析(PD)的情况下发生。明确的成功管理指南仍然难以捉摸。我们描述了在28岁男性S / P死者的供体肾移植中成功治疗EPS,以治疗继发于局灶节段性肾小球硬化(FSGS)的终末期肾脏疾病(ESRD)。该患者接受PD治疗7年,但由于透析不足的症状和体征一致,在移植的那一年改用血液透析(HD)。移植时可以看到EPS。尽管成功进行了肾脏移植,EPS仍引起小肠梗阻(SBO),需要将PEG-J放置以进行肠内营养和胃减压。患者随后发展为慢性胃皮肤瘘,因此必须进行慢性TPN并多次入院,以应对疼痛危机和肠梗阻。他当选为接受手术治疗,由于生活和发育的质量恶化。手术管理包括探查性剖腹术,广泛溶解粘连(LOA),修复胃瘘,并用Hartmann袋进行回肠造口术。术后影像学证实了SBO的分辨率,并且该患者转为使用NGT喂养,最终仅接受了PO摄取。他正在继续服用PO营养,体重增加并且没有透析。结论。 LOA的外科手术干预和小肠的释放可以成功地在适当的环境中明确管理EPS。在这种情况下,肠内营养的管理继发于持续的阻塞性发作而失败时,可以采取外科手术干预以维持生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号